Greater Precision for Transformative Drug Discovery
Brought to you by:
Target identification and characterization are key challenges in drug discovery and begin with identifying the function of a possible therapeutic target and its role in the disease. Limited Proteolysis Mass Spectrometry (LiP-MS) is a robust, reliable way to identify on- and off-target binding effects throughout the proteome, elucidate mechanisms of action and reveal potential toxicities.
Download this app note to discover how LiP-MS drug target deconvolution is:
